WEBINAR

AI for Enhanced Biomarker Discovery: Unravelling Oncological and Immunological Insights for Translational Advancements in Pharma

Are you facing challenges in identifying and validating biomarkers for your research? As a preclinical scientist, the pressure to innovate and accelerate the drug discovery process is immense.

Join our exclusive webinar to explore how human-centric AI is revolutionizing biomarker discovery in oncology and immunology.  

You'll be able to explore:

  • The Knowledge Problem in Biomarker Discovery: Uncover limitations and barriers that hinder the identification of clinically relevant biomarker in today's research landscape
  • Empowering Biomarker Research with Human-Centric AI: Discover how artificial intelligence, designed with a human-centric approach, can augment your research capabilities, streamline processes, and enhance decision-making.
  • Real-Life Applications of AI in Biomarkers Discovery: Gain insights from compelling use cases that demonstrate the transformative impact of AI on biomarker research


Who should attend this webinar?

This webinar is specifically tailored for translational scientists. If you're seeking innovative solutions to overcome biomarker discovery challenges and drive your research forward, this webinar if for you.

Don't miss this opportunity to learn from industry experts about the game-changing potential of human-centric AI in biomarkers discovery.

webinar-lp-form-icon-white

Register now

Join us to explore how AI-driven Innovation can accelerate biomarker discovery.

June 8 at 10.30AM EST | 3.30PM BST

Meet Your Hosts

1616061445848

Stavroula Ntoufa

Director of Science, Causaly

Stavroula is a Molecular Biologist and Geneticist, with a strong background in immunology, haematology and oncology. She holds a PhD from the University of Athens and has spent 13 years working in EU-funded multicentre research projects in Uppsala University, Università Vita-Salute San Raffaele, and CERTH. Stavroula has published her work in high-impact international journals. 

 

 

 

 

 

 

 

alex-thomson

Alex Thomson

Head of Presales,      Causaly

Alex is the Director of Global Pre-Sales at Causaly, a leading AI life sciences company. With a background in cell and molecular biology, he has helped many of the world’s largest healthcare organizations and pharmaceutical companies adopt leading edge AI and data strategies. Prior to joining Causaly, Alex managed strategic partnerships at 2 oncology informatics companies. Alex holds a Bachelor’s degree in Cell & Molecular Biology from the University of Toronto.